BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$644M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$501M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$465M |
| 4 |
DuPont de Nemours
DD
|
+$355M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$343M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$339M |
| 2 |
Meta Platforms (Facebook)
META
|
+$286M |
| 3 |
Visa
V
|
+$272M |
| 4 |
Apple
AAPL
|
+$185M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.84% |
| 2 | Healthcare | 8.06% |
| 3 | Consumer Discretionary | 6.44% |
| 4 | Financials | 5.46% |
| 5 | Industrials | 3.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
PUT
Shopify
SHOP
$204B
| $2.16M | ﹤0.01% |
450
-300
| -40% | -$13.2K |
|
1677
CRISPR Therapeutics
CRSP
$5.22B
| $2.16M | ﹤0.01% |
47,677
-42,591
| -47% | -$2.07M |
|
1678
Arcosa
ACA
$7.12B
| $2.15M | ﹤0.01% |
34,087
+18,691
| +121% | +$1.1M |
|
1679
National Health Investors
NHI
$3.5B
| $2.15M | ﹤0.01% |
41,666
+18,224
| +78% | +$994K |
|
1680
PUT
Enterprise Products Partners
EPD
$82.1B
| $2.14M | ﹤0.01% |
828
-902
| -52% | -$23.2K |
|
1681
Sabre
SABR
$892M
| $2.14M | ﹤0.01% |
498,838
+106,223
| +27% | +$608K |
|
1682
PUT
Colgate-Palmolive
CL
$74.1B
| $2.13M | ﹤0.01% |
284
-1,556
| -85% | -$116K |
|
1683
Valley National Bancorp
VLY
$8.3B
| $2.13M | ﹤0.01% |
230,876
+107,160
| +87% | +$1.19M |
|
1684
CALL
CF Industries
CF
$17.7B
| $2.13M | ﹤0.01% |
+294
| New | +$24K |
|
1685
OneSpan
OSPN
$624M
| $2.13M | ﹤0.01% |
121,749
+11,480
| +10% | +$172K |
|
1686
Otter Tail
OTTR
$3.9B
| $2.13M | ﹤0.01% |
29,422
+13,899
| +90% | +$923K |
|
1687
BioXcel Therapeutics
BTAI
$34.9M
| $2.12M | ﹤0.01% |
7,111
+4,900
| +222% | +$2.09M |
|
1688
UMB Financial
UMBF
$11.5B
| $2.11M | ﹤0.01% |
36,511
+11,865
| +48% | +$964K |
|
1689
CALL
Zscaler
ZS
$30.4B
| $2.1M | ﹤0.01% |
180
-410
| -69% | -$49.2K |
|
1690
ABM Industries
ABM
$2.82B
| $2.1M | ﹤0.01% |
46,674
+25,308
| +118% | +$1.17M |
|
1691
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.44B
| $2.1M | ﹤0.01% |
73,260
+5,534
| +8% | +$175K |
|
1692
Albany International
AIN
$1.82B
| $2.09M | ﹤0.01% |
23,388
+14,056
| +151% | +$1.42M |
|
1693
Federal Signal
FSS
$7.51B
| $2.09M | ﹤0.01% |
38,464
+24,827
| +182% | +$1.3M |
|
1694
Douglas Emmett
DEI
$1.99B
| $2.08M | ﹤0.01% |
168,706
+118,876
| +239% | +$1.73M |
|
|
ENLC
1695
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $2.08M | ﹤0.01% |
191,862
+37,934
| +25% | +$449K |
|
|
HTO
1696
H2O America
HTO
$2.65B
| $2.07M | ﹤0.01% |
27,158
+9,537
| +54% | +$737K |
|
|
IMGN
1697
DELISTED
Immunogen Inc
IMGN
| $2.06M | ﹤0.01% |
537,702
+174,138
| +48% | +$742K |
|
1698
Imperial Oil
IMO
$64B
| $2.05M | ﹤0.01% |
40,386
+8,938
| +28% | +$446K |
|
1699
NetEase
NTES
$78.5B
| $2.05M | ﹤0.01% |
23,195
+13,865
| +149% | +$1.2M |
|
1700
ArcBest
ARCB
$3.28B
| $2.05M | ﹤0.01% |
22,129
+4,290
| +24% | +$386K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2023 Portfolio in Review
As of Q1 2023, BNP Paribas Financial Markets held 4,166 positions worth $71.4B, up 9.7% from $65.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $2.19B of net new capital in Q1 2023, opening 167 new positions and adding to 1,965 existing holdings. Its largest new stake was iShares Preferred and Income Securities ETF: 852,962 shares worth $26.6M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $286M trimmed.
- BNP Paribas Financial Markets's largest Q1 2023 buy was iShares Preferred and Income Securities ETF: 852,962 shares worth $26.6M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $644M increase.
- BNP Paribas Financial Markets's biggest Q1 2023 reduction was Meta Platforms (Facebook), cutting an estimated $286M.
- BNP Paribas Financial Markets fully exited Linde in Q1 2023, selling an estimated $339M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $71.4B portfolio in Q1 2023.
- BNP Paribas Financial Markets opened 167 new positions and closed 322 in Q1 2023.
- BNP Paribas Financial Markets's portfolio value rose 9.7% quarter-over-quarter to $71.4B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2023, filed 12 May 2023.